STONKWHISPER
← Back to Intel
Insider ActivityMAZE

Bernstein Harold, President, R&D & CMO at Maze Therapeutics, Inc., sold $339K of MAZE

Updated Jun 17, 2026
Bernstein Harold President, R&D & CMO
Maze Therapeutics, Inc. · $MAZE
$339K Total Value
13,253 Shares Traded
$25.5746 Price / Share
1,600 Shares Owned After
2026-06-03 Filing Date

Transaction Details

InsiderBernstein Harold
TitlePresident, R&D & CMO
CompanyMaze Therapeutics, Inc.
TickerMAZE
Transaction TypeSale
Transaction Date2026-06-01
Shares Traded13,253
Price Per Share$25.5746
Total Value$339K
Filed Date2026-06-03
Accession Number0002050172-26-000023

Ownership Context

Shares Owned After Transaction1,600
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002050172-26-000023

Other Insider Trades — MAZE

Other Trades by Bernstein Harold

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MAZE — Maze Therapeutics, Inc. →

Track MAZE insider activity in real time on The Wire →

Get alerts when Bernstein Harold files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 17, 2026 at 07:04 UTC

Want real-time data? Access The Wire for live sentiment tracking.